COVID-19: WHO sees 'great news' in steroid's trial results

iStock [illustration]

The World Health Organisation (WHO) said it's updating its guidelines on COVID-19 treatment to reflect the trial results of a common steroid in critical COVID-19 cases.

The preliminary results showed that dexamethasone reduced death rates by about one third for critically ill patients.

"This is the first treatment to be shown to reduce mortality in patients with COVID-19 requiring oxygen or ventilator support," WHO Director-General Tedros Adhanom Ghebreyesus said in a statement.

The agency said it will "coordinate a meta-analysis to increase our overall understanding of this intervention" and update the guidelines to "reflect how and when the drug should be used in COVID-19".

The drug has been used since the 1960s to reduce inflammation in diseases such as arthritis.

More from International

Coming Up on Dubai Eye

  • The Night Shift with Mark Lloyd

    8:00pm - 10:00pm

    Musicians and music, entertainers and entertainment, industry gossip and songs selected by you, get ready to bring your night time to life!

  • Nights on Dubai Eye 103.8

    10:00pm - 7:00am

    Dubai Eye complements the conversation with the music you love from the eighties, nineties and newer.

On Dubai Eye

  • Dubai Eye 103.8: On The Frontline

    Dubai Eye 103.8's Georgia Tolley speaks to the Emirate's top doctors and health officials to find out why the UAE is winning the fight against COVID-19.

  • Mark's Summer Bucket List

    Mark Lloyd has been giving you ideas to keep you busy this summer, from staycations to online improv workshops!

Business Breakfast